Neurofeedback for Treatment of Central Neuropathic Pain (CNP) in Sub-acute Spinal Cord Injury (SCI)
Neurofeedback Treatment of Central Neuropathic Pain (CNP) in Sub-acute Patients With Spinal Cord Injury (SCI)
1 other identifier
interventional
20
1 country
1
Brief Summary
Spinal Cord Injury (SCI) affects a person's ability to move and feel sensation in the body. SCI is also an indirect cause of a persistent pain, called Central Neuropathic Pain (CNP). This pain typically develops several months after the injury. In 30-40% of SCI patients, severe CNP affects their everyday living including sleep and mood. Many patients give up work, not because of the injury, but because of pain. Medical treatment of CNP is moderately effective and costly, both to the patient and to the health care system. In previous research, characteristic 'signatures' of brain waves that are probably related to CNP have been defined. Based on this, a novel treatment for CNP based on neurofeedback was developed and clinically tested on five SCI patients. Electroencephalograph (EEG) was used to record patients' brain waves and these were shown to patients on a computer screen in a simple graphical form (e.g. bars). Patients were trained to change their brain activity at will and, as a consequence, their pain was reduced. Patients who had suffered from CNP for years received up to 40 neurofeedback treatment sessions, reducing their pain for several days after each session. The primary aim of this study is to apply neurofeedback therapy to a larger number of recently injured patients, who are still in a hospital. It is hypothesised that neurofeedback treatment will be more effective in people who have suffered from CNP for a shorter period of time. The secondary aim of the study is to define EEG predictors of CNP. EEG will be recorded in recently injured patients with no chronic pain, knowing that a certain number of patients will develop CNP within weeks or months. These patients will be followed up for a year and the EEGs of patients who develop CNP will be compared with those who do not.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2014
CompletedFirst Posted
Study publicly available on registry
July 1, 2014
CompletedStudy Start
First participant enrolled
August 27, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 29, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 29, 2017
CompletedMarch 1, 2019
February 1, 2019
3.3 years
June 27, 2014
February 27, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Intensity of Pain
As measured by a numerical analogue scale
1 year
Secondary Outcomes (4)
Changes in EEG activity
1 year
Changes in Spasticity
1 year
Changes in Mood
1 year
Changes in quality of sleep
1 year
Study Arms (3)
patients with central neuropathic pain
EXPERIMENTALRandomised to 20 neurofeedback therapy sessions
Control: patients with central neuropathic pain
OTHERRandomised to no neurofeedback treatment
patients with no central neuropathic pain
NO INTERVENTIONObserved for development of central neuropathic pain
Interventions
Eligibility Criteria
You may qualify if:
- Patients with Central Neuropathic Pain (Treatment and Control Groups)
- Normal or corrected to normal vision
- No history of brain disease or injury
- Incomplete/complete spinal cord injury at level C5 to T12
- Below level neuropathic pain for at least 6 weeks
- Intensity of pain 4 or above (verbal numeric scale - VNS)
- Stable medication regime responding to some extent to CNP medication treatment
- Patients with no chronic pain
- Normal or corrected to normal vision
- No history of brain disease or injury
- Incomplete/complete injury at level C5 to T12
- Within 23 months post-injury
You may not qualify if:
- Patients with Central Neuropathic Pain (Control and Treatment Groups)
- Chronic or acute muscular or visceral pain larger than 4 VNS.
- Epilepsy
- Diagnosed mental health problems
- Active intervention of pain team
- Patients with no chronic pain
- Chronic or acute pain larger than 3 on the VNS.
- Epilepsy
- Diagnosed mental health problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Greater Glasgow and Clydelead
- University of Glasgowcollaborator
Study Sites (1)
Queen Elizabeth National Spinal Injuries Unit, Southern General Hospital
Glasgow, G51 4TF, United Kingdom
Related Publications (1)
Vuckovic A, Jajrees M, Purcell M, Berry H, Fraser M. Electroencephalographic Predictors of Neuropathic Pain in Subacute Spinal Cord Injury. J Pain. 2018 Nov;19(11):1256.e1-1256.e17. doi: 10.1016/j.jpain.2018.04.011. Epub 2018 May 8.
PMID: 29751110DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2014
First Posted
July 1, 2014
Study Start
August 27, 2014
Primary Completion
November 29, 2017
Study Completion
November 29, 2017
Last Updated
March 1, 2019
Record last verified: 2019-02